Page 160 - 南京医科大学自然版

第45卷第6期
·898 · 南 京 医 科 大 学 学 报 2025年6月

［24］ITO H，SUZUKI K，MIZUTANI T，et al. Long⁃term survival small cell lung cancer：a systematic review and meta ⁃
outcome after lobectomy in patients with clinical T1 N0 analysis［J］. PLoS One，2011，6（12）：e28844
lung cancer［J］. J Thorac Cardiovasc Surg，2021，161（1）： ［35］WANG J，WANG B C，ZHAO W P，et al. Clinical signifi⁃
281-290 cance and role of lymphatic vessel invasion as a major
［25］TSAI P C，YEH Y C，HSU P K，et al. CT⁃guided core prognostic implication in non ⁃ small cell lung cancer：a
biopsy for peripheral sub ⁃ solid pulmonary nodules to meta⁃analysis［J］. PLoS One，2012，7（12）：e52704
predict predominant histological and aggressive subtypes ［36］ MOLLBERG N M，BENNETTE C，HOWELL E，et al.
of lung adenocarcinoma［J］. Ann Surg Oncol，2020，27 Lymphovascular invasion as a prognostic indicator in
（11）：4405-4412 stageⅠnon⁃small cell lung cancer：a systematic review
［26］ WANG Y，SONG W P，WANG X，et al. Does the pre ⁃ and meta⁃analysis［J］. Ann Thorac Surg，2014，97（3）：
sence of a micropapillary component predict worse prog⁃ 965-971
nosis in pathological stageⅠA lung adenocarcinoma?［J］. ［37］CAI J S，WANG X，YANG F，et al. Lymphovascular inva⁃
Pathol Res Pract，2023，242：154314 sion：a non⁃sized T descriptor for stageⅠA non⁃small cell
［27］HUANG W H，ZHANG H，ZHANG Z W，et al. A prognos⁃ lung cancer［J］. Thorac Cancer，2022，13（17）：2413-
tic nomogram based on a new classification of combined 2420
micropapillary and solid components for stageⅠA invasive ［38］ TSUTANI Y，MIYATA Y，KUSHITANI K，et al. Propensity
lung adenocarcinoma［J］. J Surg Oncol，2022，125（4）： score ⁃ matched analysis of adjuvant chemotherapy for

796-808 stageⅠnon⁃small cell lung cancer［J］. J Thorac Cardio⁃
［28］WANG C，YANG J G，LU M. Micropapillary predominant vasc Surg，2014，148（4）：1179-1185
lung adenocarcinoma in stageⅠA benefits from adjuvant ［39］ TSUCHIYA T，KAMOHARA R，MURAOKA M，et al. A
chemotherapy［J］. Ann Surg Oncol，2020，27（6）：2051- single⁃arm，phase 2 study of adjuvant chemotherapy with
2060 oral tegafur ⁃ uracil for pathologically lymphovascular
［29］SUMIYOSHI S，YOSHIZAWA A，SONOBE M，et al. Pul⁃ invasion positive stageⅠA non⁃small cell lung cancer：
monary adenocarcinomas with micropapillary component LOGIK0602 study［J］. BMC Cancer，2020，20（1）：1192
significantly correlate with recurrence，but can be well ［40］TRAVIS W D，BRAMBILLA E，BURKE A P，et al. Intro⁃
controlled with EGFR tyrosine kinase inhibitors in the duction to the 2015 World Health Organization classifica⁃
early stages［J］. Lung Cancer，2013，81（1）：53-59 tion of tumors of the lung，pleura，thymus，and heart［J］. J
［30］SHI Y K，LI J L，ZHANG S C，et al. Molecular epidemiology Thorac Oncol，2015，10（9）：1240-1242
of EGFR mutations in Asian patients with advanced non⁃ ［41］KIM S K，KIM T J，CHUNG M J，et al. Lung adenocarci⁃
small⁃cell lung cancer of adenocarcinoma histology⁃ main⁃ noma：CT features associated with spread through air
land China subset analysis of the PIONEER study［J］. spaces［J］. Radiology，2018，289（3）：831-840
PLoS One，2015，10（11）：e0143515 ［42］YIN Q F，WANG H E，CUI H S，et al. Meta⁃analysis of
［31］OKIROR L，HARLING L，TOUFEKTZIAN L，et al. Prog⁃ association between CT⁃based features and tumor spread
nostic factors including lymphovascular invasion on sur⁃ through air spaces in lung adenocarcinoma［J］. J Cardio⁃
vival for resected non⁃small cell lung cancer［J］. J Thorac thorac Surg，2020，15（1）：243
Cardiovasc Surg，2018，156（2）：785-793 ［43］ CHAE M，JEON J H，CHUNG J H，et al. Prognostic
［32］CHOE J，KIM M Y，YUN J K，et al. Sublobar resection in significance of tumor spread through air spaces in
stageⅠA non⁃small cell lung cancer：role of preoperative patients with stageⅠA part⁃solid lung adenocarcinoma
CT features in predicting pathologic lymphovascular after sublobar resection［J］. Lung Cancer，2021，152：21-
invasion and postoperative recurrence［J］. AJR Am J 26
Roentgenol，2021，217（4）：871-881 ［44］ TAKEHANA K，SAKAMOTO R，FUJIMOTO K，et al.
［33］ LIU K F，LIN X F，CHEN X J，et al. Development and Peritumoral radiomics features on preoperative thin⁃slice
validation of a deep learning signature for predicting CT images can predict the spread through air spaces of
lymphovascular invasion and survival outcomes in clinical lung adenocarcinoma［J］. Sci Rep，2022，12（1）：10323
stageⅠA lung adenocarcinoma：a multicenter retrospective ［45］CHEN D L，WANG X F，ZHANG F Q，et al. Could tumor
cohort study［J］. Transl Oncol，2024，42：101894 spread through air spaces benefit from adjuvant chemo⁃
［34］WANG J，CHEN J P，CHEN X，et al. Blood vessel inva⁃ therapy in stage I lung adenocarcinoma?A multi⁃institu⁃
sion as a strong independent prognostic indicator in non⁃ tional study［J］. Ther Adv Med Oncol，2020，12：17588359